Impact of sauerkraut consumption on metabolic control, inflammatory status and host-microbiome-interactions

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00027007

Enrollment

100

Registered

2021-10-29

Start date

2021-10-11

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

Group 1: 100g EDEN Frischkost-L(+)-Sauerkraut daily for four weeks Group 2: 100g sauerkraut EDEN mild daily for four weeks

Eligibility

Sex/Gender

All

Age

20 Years to 68 Years

Inclusion criteria

Inclusion criteria: BMI = 18,5 - 30 kg/m² healthy non-smokers

Exclusion criteria

Exclusion criteria: No antibiotic intake = 3 months before the start of the study no chronic or acute gastrointestinal diseases or more serious gastrointestinal surgery hypertension Diabetes mellitus Cancer diseases or acute cardiovascular events = 3 months before the start of the study Taking proton pump inhibitors The following dietary restrictions: veganism, diet exclusively from raw foods as well as eating disorders

Design outcomes

Primary

Measure	Time frame
impact of fresh and pasteurized sauerkraut on the composition of the bacterial gut microbiome and metabolome (metabolomics and metagenomic analysis in stool samples before and after each intervention)	—

Secondary

Measure	Time frame
impact of fresh and pasteurized sauerkraut on different health markers in the blood (metabolic and inflammatory status, blood pressure, leaky gut markers)	—

Countries

Germany

Contacts

Public ContactNelly Schropp

Universitätsklinikum Freiburg

ipe.sauerkraut-studie@uniklinik-freiburg.de+49 761 270-77320

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026